АШУҮИС — Судалгааны мэдээлэл (CRIS)
Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001
Browse
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Erdene urel on Microglia / Macrophage Distribution and Inhibition of Inflammatory Response after Brain Ischemia in Rats(Mongolian National University of Medical Sciences, 2020-04-01) ;Hu Yu Rong ;Khaliunaa Tumurbaatar ;B. Gansukh; Chimedragchaa ChimedtserenObjectives: We studied the effect of Erdene urel on microglia/macrophage M1/M2 distribution and neuroinflammation using a cerebral ischemia-reperfusion injury model in rats. Methods: The middle cerebral artery occluded by thread occlusion, followed by reperfusion at 90 minutes after ischemia. The injury was studied at 1, 3, and 7 days after brain ischemia, and the neurological score was graded, after that, the brain tissue was collected by decollation. The phenotypes of M1 and M2 were detected by Iba1 and Arg-1 immunofluorescence, and the expressions of (TNF-D), (IL-1E), (IL-6), and (IL-10) were detected by ELISA. Result: The immunofluorescence showed that compared with the sham-operated group, the microglia/ macrophage (Iba1) in the ischemic area of the control group’s rats with middle cerebral artery occlusion and to which reperfusion was performed for 1, 3 and 7 days was increased (p<.05) and the number of M2 (Arg-1) (p<.05) was reduced. One day after reperfusion, the Erdene urel and nimodipine groups did not differ from the control group. However, after 3 and 7 days, the microglia/macrophage (Iba1) (p<.05) in the ischemic area of Erdene urel and nimodipine groups was reduced, while M2 (Arg-1) (p<.05) was increased. Conclusion: Erdene urel is likely capable of promoting the transformation of activated microglia/macrophages from M1 to M2. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Astragalus Mongholicus Bunge Extract on Isoproterenol-Induced Myocardial Infarction in Rats(Mongolian National University of Medical Sciences, 2020-09-25); ;Anu Altangerel ;Yan Zhang ;B. GansukhObjectives: Our study’s objective was to investigate the cardioprotective effects of Astragalus mongholicus Bunge, a herbal medicine cultivated in Mongolia. Methods: Fifty rats were divided into five groups of ten. The untreated control and treatment group rats received isoproterenol (150 mg/kg) by subcutaneous injection for two consecutive days on 29th and 30th days to induce myocardial infarction. The treatment groups received Astragalus mongholicus Bunge 71, 142, or 284 mg/kg for 28 days prior to infarction. At the end of the experiment, Astragalus mongholicus Bunge’s cardioprotective effect was assessed through histopathology, the measurement of serum CK, AST, ALT, and LDH, and the oxidative stress markers malondialdehyde and total superoxide dismutase. Results: Treatment with Astragalus mongholicus Bunge 71 mg/kg caused significant decreases in the levels of LDH, AST, and CK serum compared with the control group (p < 0.05). Treatment with Astragalus mongholicus Bunge at 71, 142, and 284 mg/kg showed a significant decrease in malondialdehyde compared with the control group (p < 0.05). Treatment with Astragalus mongholicus Bunge at the same levels significantly reduced myocardial damage by protecting levels of the beneficial antioxidant enzyme total superoxide dismutase (p < 0.05). Histopathological examination of the group treated with Astragalus mongholicus Bunge 142 mg/kg showed a decreased area with necrosis and inflammatory cells in the myocardial tissue. Conclusion: The protective effect of Astragalus mongholicus Bunge occurs by protecting the myocardium’s native superoxide dismutase levels, reducing the levels of malondialdehyde and serum marker enzymes LDH, AST, and CK.
